Table Of Contents

1. Introduction

 1.1 AI in Pathology Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 AI in Pathology Market Snapshot

 2.2 AI in Pathology Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 AI in Pathology Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 AI in Pathology Market Size By Neural Network Type

  2.3.2 AI in Pathology Market Size By Product Type

  2.3.3 AI in Pathology Market Size By Type

  2.3.4 AI in Pathology Market Size By End User

  2.3.5 AI in Pathology Market Size By Application

 2.4 AI in Pathology Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. AI in Pathology Market Overview

 3.1 AI in Pathology Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key AI in Pathology Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting AI in Pathology Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers (Hardware Components & AI Algorithms)

  3.4.2 Manufacturers (Scanners, Software Developers)

  3.4.3 Distributors/Suppliers (LIS Integrators, Cloud Platforms)

  3.4.4 Customers/End-Users (Labs, Hospitals, Pharma Companies)

 3.5 Industry Life Cycle Assessment

 3.6 Parent Digital Pathology Market Overview

 3.7 AI in Pathology Market Risk Assessment

4. Statistical Insights & Trends Reporting (AI in Pathology)

4.1 Pricing Analysis & Forecast

  4.1.1 Overview

  4.1.2 Average Software Licensing Cost (Per Seat / Annual Subscription)

  4.1.3 Price Benchmarking by AI Solution (Cancer Detection vs. Rare Disease)

  4.1.4 Regional Pricing Differences (North America vs. Asia-Pacific)

  4.1.5 Emerging Pricing Models (Pay-per-Slide, Value-Based Agreements)

4.2 Regulatory & Compliance Landscape

  4.2.1 Overview

  4.2.2 Compliance with FDA (USA), IVDR (Europe), and CDSCO (India) Regulations

  4.2.3 Insurance and Reimbursement Frameworks for AI-Based Diagnostics

  4.2.4 Policies Promoting AI Integration in Clinical Workflows

  4.2.5 Strategic Guidelines for Compliance and Risk Management (Bias & Explainability)

4.3 Technology & Innovation Metrics

  4.3.1 Overview

  4.3.2 Adoption Rate of Whole Slide Imaging (WSI) with AI Integration

  4.3.3 Investment in Foundation Models & Generative AI for Histopathology

  4.3.4 Patent Filings in CNN, GAN, and MVPNet Architectures for Pathology

  4.3.5 Emerging Trends: Multimodal AI (Genomics + Imaging), Federated Learning, and Real-Time Telepathology

4.4 Operational & Diagnostic Metrics

  4.4.1 Overview

  4.4.2 Number of AI-Assisted Pathology Reports Generated Per Year

  4.4.3 Algorithm Sensitivity & Specificity Benchmarks (Cancer vs. Benign)

  4.4.4 Average Turnaround Time Reduction (Manual vs. AI-Powered Diagnosis)

  4.4.5 Safety Records, False Positive/Negative Rates, and Model Drift Frequency

4.5 Investment & Strategic Activity

  4.5.1 Overview

  4.5.2 Venture Capital and Private Equity Investments in AI Pathology Startups

  4.5.3 Key M&A Activity and Strategic Partnerships (LIS + AI Providers)

  4.5.4 Collaborations Between Pharma CROs, AI Labs, and Academic Medical Centers

  4.5.5 Emerging Innovation Hubs and R&D Centers for Computational Pathology

5. AI in Pathology Market Segmental Analysis & Forecast, By Neural Network Type, 2022–2035, Value (USD Million)

5.1 Introduction

 5.2 Convolutional Neural Networks (CNNs)

  5.2.1 Key Trends

  5.2.2 AI in Pathology Market Size & Forecast, 2022–2035

 5.3 Recurrent Neural Networks (RNNs)

 5.4 Generative Adversarial Networks (GANs)

 5.5 MVPNet

 5.6 Reinforced Auto Zoom Net

6. AI in Pathology Market Segmental Analysis & Forecast, By Product Type, 2022–2035, Value (USD Million)

    6.1 Introduction

 6.2 Scanners

  6.2.1 Key Trends

  6.2.2 AI in Pathology Market Size & Forecast, 2022–2035

 6.3 Software

 6.4 Communication Systems

 6.5 Storage Systems

7. AI in Pathology Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Million)

    7.1 Introduction

 7.2 Human Pathology

  7.2.1 Key Trends

  7.2.2 AI in Pathology Market Size & Forecast, 2022–2035

 7.3 Veterinary Pathology

8. AI in Pathology Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Million)

    8.1 Introduction

 8.2 Pharmaceutical and Biotechnology Companies

  8.2.1 Key Trends

  8.2.2 AI in Pathology Market Size & Forecast, 2022–2035

 8.3 Hospitals and Reference Laboratories

 8.4 Academic and Research Institutes

9. AI in Pathology Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Million)

    9.1 Introduction

 9.2 Teleconsultation

  9.2.1 Key Trends

  9.2.2 AI in Pathology Market Size & Forecast, 2022–2035

 9.3 Disease Diagnosis

 9.4 Drug Discovery

 9.5 Training and Education

10. AI in Pathology Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Million)

10.1 Introduction

10.2 North America

 10.2.1 Key Trends

 10.2.2 AI in Pathology Market Size & Forecast, By Neural Network Type, 2022–2035

 10.2.3 AI in Pathology Market Size & Forecast, By Product Type, 2022–2035

 10.2.4 AI in Pathology Market Size & Forecast, By Type, 2022–2035

 10.2.5 AI in Pathology Market Size & Forecast, By End User, 2022–2035

 10.2.6 AI in Pathology Market Size & Forecast, By Application, 2022–2035

 10.2.7 AI in Pathology Market Size & Forecast, By Country, 2022–2035

  10.2.7.1 USA

  10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 AI in Pathology Market Size & Forecast, By Neural Network Type, 2022–2035

 10.3.3 AI in Pathology Market Size & Forecast, By Product Type, 2022–2035

 10.3.4 AI in Pathology Market Size & Forecast, By Type, 2022–2035

 10.3.5 AI in Pathology Market Size & Forecast, By End User, 2022–2035

 10.3.6 AI in Pathology Market Size & Forecast, By Application, 2022–2035

 10.3.7 AI in Pathology Market Size & Forecast, By Country, 2022–2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 AI in Pathology Market Size & Forecast, By Neural Network Type, 2022–2035

 10.4.3 AI in Pathology Market Size & Forecast, By Product Type, 2022–2035

 10.4.4 AI in Pathology Market Size & Forecast, By Type, 2022–2035

 10.4.5 AI in Pathology Market Size & Forecast, By End User, 2022–2035

 10.4.6 AI in Pathology Market Size & Forecast, By Application, 2022–2035

 10.4.7 AI in Pathology Market Size & Forecast, By Country, 2022–2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 AI in Pathology Market Size & Forecast, By Neural Network Type, 2022–2035

 10.5.3 AI in Pathology Market Size & Forecast, By Product Type, 2022–2035

 10.5.4 AI in Pathology Market Size & Forecast, By Type, 2022–2035

 10.5.5 AI in Pathology Market Size & Forecast, By End User, 2022–2035

 10.5.6 AI in Pathology Market Size & Forecast, By Application, 2022–2035

 10.5.7 AI in Pathology Market Size & Forecast, By Country, 2022–2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 AI in Pathology Market Size & Forecast, By Neural Network Type, 2022–2035

 10.6.3 AI in Pathology Market Size & Forecast, By Product Type, 2022–2035

 10.6.4 AI in Pathology Market Size & Forecast, By Type, 2022–2035

 10.6.5 AI in Pathology Market Size & Forecast, By End User, 2022–2035

 10.6.6 AI in Pathology Market Size & Forecast, By Application, 2022–2035

 10.6.7 AI in Pathology Market Size & Forecast, By Country, 2022–2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 Egypt

  10.6.7.5 South Africa

  10.6.7.6 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Key Strategies Adopted (%), By Key Players, 2025

  11.2.2 Year-Wise Strategies & Development, 2022–2025

  11.2.3 Number Of Strategies Adopted By Key Players, 2025

 11.3 AI in Pathology Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

12. Key Company Profiles

12.1 PathAI

 12.1.1 Company Overview & Snapshot

 12.1.2 Product/Service Portfolio

 12.1.3 Key Company Financials

 12.1.4 SWOT Analysis

12.2 Paige AI

12.3 Proscia

12.4 Ibex Medical Analytics

12.5 Aiforia Technologies

12.6 Akoya Biosciences

12.7 Indica Labs

12.8 Roche Diagnostics

12.9 Koninklijke Philips N.V. (Philips Digital/Computational Pathology)

12.10 Hologic, Inc.

12.11 OptraScan, Inc.

12.12 Mindpeak GmbH

12.13 Tribun Health

12.14 Deep Bio, Inc.

12.15 Visiopharm A/S

12.16 Techcyte, Inc.

12.17 Tempus AI, Inc.

12.18 Huron Digital Pathology

12.19 Inspirata, Inc.

12.20 Sectra AB

13. Analyst Recommendations

 13.1 SNS Insider Opportunity Map

 13.2 Industry Low-Hanging Fruit Assessment

 13.3 AI in Pathology Market Entry & Growth Strategy

 13.4 Analyst Viewpoint & Suggestions on AI in Pathology Market Growth

14. Assumptions

15. Disclaimer

16. Appendix

 16.1 List Of Tables

 16.2 List Of Figures